Global Soft Tissue Allografts Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
- Published Date: 2021-04-23
- Report ID: 106239
- Pages: 114
-
Format:
Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Prudent Markets published a report for global Soft Tissue Allografts market in this environment.
In terms of revenue, this research report indicated that the global Soft Tissue Allografts market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Soft Tissue Allografts industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Allergan Plc aims at producing XX K Units Soft Tissue Allografts in 2020, with XX % production to take place in global market, B. Braun accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Soft Tissue Allografts Market by Prudent Markets Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Soft Tissue Allografts Market
Allergan Plc
B. Braun
CONMED Corporation
Xtant Medical Holdings, Inc.
Alliqua BioMedical, Inc.
Alon Source Group
C. R. Bard, Inc.
Arthrex, Inc.
Bone Bank Allografts
Osiris Therapeutics, Inc.
MiMedx Group, Inc.
Integra LifeSciences Corporation
Organogenesis Inc.
RTI Surgical, Inc.
Lattice Biologics Ltd.
Globus Medical, Inc.
Zimmer Biomet Holdings, Inc.
Straumann Holding AG
...
Major Type of Soft Tissue Allografts Covered in Prudent Markets report:
Cartilage
Tendon Allograft
Meniscus Allograft
Dental Allograft
Collagen Allograft
Amniotic Allograft
Application Segments Covered in Prudent Markets Market
Orthopedic
Dentistry
Wound Care
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Soft Tissue Allografts Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Cartilage -Product Introduction and Major Manufacturers
1.1.2 Tendon Allograft -Product Introduction and Major Manufacturers
1.1.3 Meniscus Allograft -Product Introduction and Major Manufacturers
1.1.4 Dental Allograft -Product Introduction and Major Manufacturers
1.1.5 Collagen Allograft -Product Introduction and Major Manufacturers
1.1.6 Amniotic Allograft -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Soft Tissue Allografts Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis
3.1 China Soft Tissue Allografts Market
3.1.1 Top Companies leading Soft Tissue Allografts Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Soft Tissue Allografts Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)
3.2 EU Soft Tissue Allografts Market
3.2.1 Top Companies leading Soft Tissue Allografts Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Soft Tissue Allografts Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)
3.3 USA Soft Tissue Allografts Market
3.3.1 Top Companies leading Soft Tissue Allografts Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Soft Tissue Allografts Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)
3.4 Japan Soft Tissue Allografts Market
3.4.1 Top Companies leading Soft Tissue Allografts Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Soft Tissue Allografts Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)
3.5 India Soft Tissue Allografts Market
3.5.1 Top Companies leading Soft Tissue Allografts Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Soft Tissue Allografts Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)
3.6 Southeast Asia Soft Tissue Allografts Market
3.6.1 Top Companies leading Soft Tissue Allografts Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Soft Tissue Allografts Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Soft Tissue Allografts Market
3.7.1 Top Companies leading Soft Tissue Allografts Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Soft Tissue Allografts Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)
4.1 Soft Tissue Allografts Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Soft Tissue Allografts Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)
5.1 Global Soft Tissue Allografts Sales and Growth Rate (2021-2027)
5.2 Global Soft Tissue Allografts Sales Value and Growth Rate (2021-2027)
6 Soft Tissue Allografts Competitive Analysis
6.1 Allergan Plc
6.1.1 Allergan Plc Company Profiles
6.1.2 Allergan Plc Product Introduction
6.1.3 Allergan Plc Soft Tissue Allografts Production, Revenue (2016-2021)
6.1.4 SWOT Analysis
6.2 B. Braun
6.2.1 B. Braun Company Profiles
6.2.2 B. Braun Product Introduction
6.2.3 B. Braun Soft Tissue Allografts Production, Revenue (2016-2021)
6.2.4 SWOT Analysis
6.3 CONMED Corporation
6.3.1 CONMED Corporation Company Profiles
6.3.2 CONMED Corporation Product Introduction
6.3.3 CONMED Corporation Soft Tissue Allografts Production, Revenue (2016-2021)
6.3.4 SWOT Analysis
6.4 Xtant Medical Holdings, Inc.
6.4.1 Xtant Medical Holdings, Inc. Company Profiles
6.4.2 Xtant Medical Holdings, Inc. Product Introduction
6.4.3 Xtant Medical Holdings, Inc. Soft Tissue Allografts Production, Revenue (2016-2021)
6.4.4 SWOT Analysis
6.5 Alliqua BioMedical, Inc.
6.5.1 Alliqua BioMedical, Inc. Company Profiles
6.5.2 Alliqua BioMedical, Inc. Product Introduction
6.5.3 Alliqua BioMedical, Inc. Soft Tissue Allografts Production, Revenue (2016-2021)
6.5.4 SWOT Analysis
6.6 Alon Source Group
6.6.1 Alon Source Group Company Profiles
6.6.2 Alon Source Group Product Introduction
6.6.3 Alon Source Group Soft Tissue Allografts Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 C. R. Bard, Inc.
6.7.1 C. R. Bard, Inc. Company Profiles
6.7.2 C. R. Bard, Inc. Product Introduction
6.7.3 C. R. Bard, Inc. Soft Tissue Allografts Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 Arthrex, Inc.
6.8.1 Arthrex, Inc. Company Profiles
6.8.2 Arthrex, Inc. Product Introduction
6.8.3 Arthrex, Inc. Soft Tissue Allografts Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 Bone Bank Allografts
6.9.1 Bone Bank Allografts Company Profiles
6.9.2 Bone Bank Allografts Product Introduction
6.9.3 Bone Bank Allografts Soft Tissue Allografts Production, Revenue (2016-2021)
6.9.4 SWOT Analysis
6.10 Osiris Therapeutics, Inc.
6.10.1 Osiris Therapeutics, Inc. Company Profiles
6.10.2 Osiris Therapeutics, Inc. Product Introduction
6.10.3 Osiris Therapeutics, Inc. Soft Tissue Allografts Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
6.11 MiMedx Group, Inc.
6.12 Integra LifeSciences Corporation
6.13 Organogenesis Inc.
6.14 RTI Surgical, Inc.
6.15 Lattice Biologics Ltd.
6.16 Globus Medical, Inc.
6.17 Zimmer Biomet Holdings, Inc.
6.18 Straumann Holding AG
7 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
